Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the management of obesity. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://donnacvgc951268.blazingblog.com/39016616/semaglutide-a-potential-solution-for-obesity